Fecal microbiota transplantation as an effective initial therapy for pancreatitis complicated with severe Clostridium difficile infection: A case report

Table 1 Laboratory findings of the patient

Testing item	Results	Reference range
WBC, count/mL	12360	3500-9500
HCT, %	46.9	43-58.0
Serum amylase, IU/L	156	20-110
c(Ca2+), mmol/L	1.79	2.11-2.52
CRP, mg/L	141	<10
Alb, g/L	26.8	40.0-55.0
LDH, U/L	529	120-250
FBG, mmol/L	5.86	3.9-6.1
ESR, mm/h	69	<20
HIV	(-)	(-)
HBsAg	(-)	(-)
HCV-Ab	(-)	(-)

WBC: White blood cells; HCT: Haematocrit; CRP: C-reactive protein; Alb: Albumin; LDH: Lactic dehydrogenase; FBG: Fasting blood-glucose; ESR: erythrocyte sedimentation rate; HIV: Human immunodeficiency virus; HCV: Hepatitis C virus.

Table 2 Published reports of fecal microbiota transplantation in patients with primary Clostridium difficile infection worldwide

Patient	Sex	Age(yr)	Complication	Antibiotics	EIA for toxins	Fecal material delivery	Adverseevents
1	M	51	MSAP	-	Positive for toxin- producing C. difficile and toxin B	Nasogastric tube	None
2[16]	F	64	Dental pain and infections	Clindamycin	Positive for C. difficile toxin and GDH	Colonoscopy	None
3[15]	F (4) M (5)	67 (34-88)	-	Yes		Retention enema	(1) A foul smell from the patient's stool; (2) No clinical symptoms but an increase in the CRP levels a few days after treatment

EIA: Enzyme immunoassay; MSAP: Moderately severe acute pancreatitis; GDH: Glutamate dehydrogenase; C. difficile: Clostridium difficile.